<?xml version="1.0"?>
<rss version="2.0" xmlns:blogChannel="http://backend.userland.com/blogChannelModule">
	<channel>
		<title>Medscape Rheumatology Headlines</title>
		<link>http://www.medscape.com/rheumatology?src=rss</link>
		<description>Latest medical news, articles, and features from Medscape Rheumatology</description>
		<image>
			<url>http://images.medscape.com/pi/global/logos/mscp/logo-medscape110x30.gif</url>
			<title>Medscape Rheumatology Headlines</title>
			<link>http://www.medscape.com/rheumatology?src=rss</link>
		</image>
		<language>en-us</language>
		<copyright>Copyright 2008, Medscape</copyright>
		<pubDate>Mon, 12 May 2008 06:04:53 EDT</pubDate>
		<managingEditor>rheumatologyeditor@medscape.net</managingEditor>
		<webMaster>medscapecustomersupport@webmd.net (Medscape Customer Support)</webMaster>

		<item>
			<title>Icyou: How Social Media Is the New Resource for Online Health Information</title>
			<link>http://www.medscape.com/viewarticle/573272?src=rss</link>
			<description>Prerna Mona Khanna, MD, MPH, Medical Editor, Icyou.com, Charleston, South Carolina, describes another promising use of the health Internet. 
  &lt;br /&gt; &lt;i&gt;The Medscape Journal of Medicine&lt;/i&gt;</description>
			<category>Internal Medicine</category>
					<pubDate>Fri, 9 May 2008 09:16:25 EDT</pubDate>
		</item>
		<item>
			<title>Rheumatoid Arthritis is Milder in the New Millennium: Health status in RA patients 1994-2004: Commentary from F1000</title>
			<link>http://www.medscape.com/viewarticle/572275?src=rss</link>
			<description>Start RA treatment early and aggressively: A practice-changing study 
  &lt;br /&gt; &lt;i&gt;Faculty of 1000 Medicine&lt;/i&gt;</description>
			<category>Rheumatology</category>
					<pubDate>Fri, 9 May 2008 18:19:43 EDT</pubDate>
		</item>
		<item>
			<title>FDA Safety Changes: Janumet, WelChol, Rituxan</title>
			<link>http://www.medscape.com/viewarticle/574124?src=rss</link>
			<description>The FDA has approved revisions to the safety labeling for sitagliptin plus metformin HCl tablets (Janumet), colesevelam HCl tablets (WelChol), and rituximab intravenous injection (Rituxan).  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Pharmacist</category>
					<pubDate>Wed, 7 May 2008 17:00:00 EDT</pubDate>
		</item>
		<item>
			<title>Sulfasalazine for Rheumatoid Arthritis May Cause Severe Hepatotoxicity</title>
			<link>http://www.medscape.com/viewarticle/574111?src=rss</link>
			<description>Potentially fatal hepatotoxicity can be triggered by sulfasalazine therapy for rheumatoid arthritis, according to a series of case reports investigated by UK researchers.  &lt;br /&gt; &lt;i&gt;Reuters Health Information&lt;/i&gt;</description>
			<category>Rheumatology</category>
					<pubDate>Wed, 7 May 2008 00:37:20 EDT</pubDate>
		</item>
		<item>
			<title>How to Treat Skin Infections, Including MRSA, in 2008</title>
			<link>http://www.medscape.com/viewarticle/573107?src=rss</link>
			<description>Erik Schraga, MD, with Stanford-Kaiser Santa Clara Emergency Medicine in California, explains the correct way to treat skin abscesses in 2008. 
  &lt;br /&gt; &lt;i&gt;The Medscape Journal of Medicine&lt;/i&gt;</description>
			<category>Internal Medicine</category>
					<pubDate>Mon, 5 May 2008 08:46:39 EDT</pubDate>
		</item>
		<item>
			<title>Height Loss Measurement Improves Sensitivity of Osteoporosis Diagnosis</title>
			<link>http://www.medscape.com/viewarticle/574007?src=rss</link>
			<description>Poor association between bone mineral density and vertebral fractures leads to misclassification of many osteoporotic patients.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Internal Medicine</category>
					<pubDate>Mon, 5 May 2008 11:15:00 EDT</pubDate>
		</item>
		<item>
			<title>Guidelines Issued for Screening Men for Osteoporosis</title>
			<link>http://www.medscape.com/viewarticle/573982?src=rss</link>
			<description>The American College of Physicians recommend that clinicians assess risk factors for osteoporosis in older men and obtain a bone mineral density test for men at increased risk for osteoporosis.  &lt;br /&gt; &lt;i&gt;Medscape Medical News&lt;/i&gt;</description>
			<category>Rheumatology</category>
					<pubDate>Mon, 5 May 2008 17:00:00 EDT</pubDate>
		</item>
		<item>
			<title>Abatacept Shows Ongoing Benefit in Arthritis Patients</title>
			<link>http://www.medscape.com/viewarticle/574043?src=rss</link>
			<description>The results of a 2-year follow-up study of patients with rheumatoid arthritis who received a combination of abatacept and methotrexate show the initial benefits of treatment are maintained and might even be enhanced.  &lt;br /&gt; &lt;i&gt;Reuters Health Information&lt;/i&gt;</description>
			<category>Rheumatology</category>
					<pubDate>Tue, 6 May 2008 11:12:51 EDT</pubDate>
		</item>
		<item>
			<title>MR Imaging of Femoroacetabular Impingement</title>
			<link>http://www.medscape.com/viewarticle/573242?src=rss</link>
			<description>Femoroacetabular impingement (FAI) and its link to early hip osteoarthritis requires early diagnosis and treatment to prevent/delay degeneration in younger patients. What are the MRI findings of FAI? 
  &lt;br /&gt; &lt;i&gt;Applied Radiology&lt;/i&gt;</description>
			<category>Radiology</category>
					<pubDate>Thu, 8 May 2008 14:06:18 EDT</pubDate>
		</item>
		<item>
			<title>SLE Patients With Renal Damage Incur Higher Health Care Costs</title>
			<link>http://www.medscape.com/viewarticle/573155?src=rss</link>
			<description>Systemic lupus erythematosus (SLE) patients with renal damage incurred higher direct costs, but did not experience a poorer quality of life, according to this study. 
  &lt;br /&gt; &lt;i&gt;Rheumatology&lt;/i&gt;</description>
			<category>Rheumatology</category>
					<pubDate>Mon, 5 May 2008 17:09:08 EDT</pubDate>
		</item>

</channel>
</rss>